|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3283527 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16718802.8 |
| Date of filing the European patent application | 2016-04-12 | |
| (97) | Date of publication of the European application | 2018-02-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-13 |
| (46) | Date of publication of the claims translation | 2021-03-25 |
| (86) | Number | PCT/US2016/027038 |
| Date | 2016-04-12 |
| (87) | Number | WO 2016/168149 |
| Date | 2016-10-20 |
| (30) | Number | Date | Country code |
| 201562146766 P | 2015-04-13 | US | |
| 201562190945 P | 2015-07-10 | US |
| (72) |
MASTELLER, Emma, US
BRENNAN, Thomas, US
BELLOVIN, David, US
BAKER, Kevin, US
WONG, Brian, US
|
| (73) |
Five Prime Therapeutics, Inc.,
111 Oyster Point Boulevard, South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompleksinė terapija vėžio gydymui |
| COMBINATION THERAPY FOR CANCER |
| Payment date | Validity (years) | Amount | |
| 2024-03-07 | 9 | 208.00 EUR |
| 2025-04-12 |